2025-05-02 09:19:49
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Gufic Biosciences posts Rs. 21.03 crores PAT in Q3 FY2021-22
Posted On : 2022-02-09 21:55:28( TIMEZONE : IST )
Gufic Biosciences Limited has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 173.5967 crores during the period ended December 31, 2021 as compared to Rs. 194.4444 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 21.0326 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 23.3362 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 2.17 for the period ended December 31, 2021 as compared to Rs. 2.41 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 173.5967 crs | ₹194.4444 crs |  -10.72% |
| Net Profit | ₹21.0326 crs | ₹23.3362 crs | -9.87% |
| EPS | ₹2.17 | ₹2.41 | -9.96% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 173.5967 crores during the period ended December 31, 2021 as compared to Rs.166.5897 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.21.0326 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.15.4648 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.2.17 for the period ended December 31, 2021 as compared to Rs.1.60 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 173.5967 crs | ₹166.5897 crs |  4.21% |
| Net Profit | ₹21.0326 crs | ₹15.4648 crs | 36.00% |
| EPS | ₹2.17 | ₹1.60 | 35.63% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.620.0260 crores during the 9 Months period ended December 31, 2021 as compared to Rs.358.8467 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.75.5759 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.31.3612 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.7.80 for the 9 Months period ended December 31, 2021 as compared to Rs.3.23 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹620.0260 crs | ₹358.8467 crs | 72.78% |
| Net Profit | ₹75.5759 crs | ₹31.3612 crs | 140.99% |
| EPS | ₹7.80 | ₹3.23 | 141.49% |
Shares of Gufic Biosciences Limited was last trading in BSE at Rs. 237.30 as compared to the previous close of Rs. 234.30. The total number of shares traded during the day was 38696 in over 1306 trades.
The stock hit an intraday high of Rs. 243.00 and intraday low of 229.25. The net turnover during the day was Rs. 9138620.00.
